COMMUNIQUÉS West-GlobeNewswire

AllSpire Health GPO Adopts Lumere’s Solutions to Support Value-Based Initiatives
27/02/2018
CHICAGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AllSpire Health GPO, LLC—a health system alliance created to escalate the improvement of clinical outcomes, enable greater access to affordable healthcare, ensure economic [...]
Les infirmières et les infirmiers du Canada accueillent favorablement les nouvelles au sujet d’un groupe de travail national sur la mise en place d’un régime d’assurance-médicaments
27/02/2018
OTTAWA, 27 févr. 2018 (GLOBE NEWSWIRE) -- Les infirmières et les infirmiers du Canada accueillent favorablement les récentes nouvelles communiquées dans les médias selon lesquelles l’Honorable Eric Hoskins sera à la [...]
RAMSAY GENERALE DE SANTE : Half-year Results at the end of December 2017
27/02/2018
PRESS RELEASE Paris, 27 February 2018 Half-year results at the end of December 2017 Declining results in a still very negative pricing environment Published half-year turnover down 1.1% to €1,066.4 million, stable on a [...]
RAMSAY GENERALE DE SANTE : Résultats semestriels à fin décembre 2017
27/02/2018
COMMUNIQUE DE PRESSE Paris, le 27 Février 2018 Résultats semestriels à fin décembre 2017 Des résultats en repli dans un contexte tarifaire toujours très pénalisant Chiffre d'affaires semestriel publié en recul de 1,1% à [...]
The EMA Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in HAE Patients Aged 12 Years and Older
27/02/2018
The European Medicines Agency (EMA) Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in Hereditary Angioedema (HAE) Patients Aged 12 Years and Older - EMA's accelerated [...]
SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)
27/02/2018
PHILADELPHIA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing metabolic-based therapies focused on non-alcoholic steatohepatitis (NASH), announced today the [...]
Canada’s nurses welcome reports of a federal pharmacare task force
27/02/2018
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses welcome recent media reports that the Hon. Eric Hoskins will lead a task force on national pharmacare. The Canadian Federation of Nurses Unions (CFNU) has been [...]
Novo Nordisk files for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A
27/02/2018
Bagsværd, Denmark, 27 February 2018 - Novo Nordisk today announced the submission of a Biologics License Applications (BLA) to the US Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to [...]
Vizient, Inc. Awards National Contract to PDC Healthcare for Patient ID Bands
27/02/2018
VALENCIA, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Dynamics Corporation (PDC Healthcare) , a global leader in healthcare identification and patient safety solutions, announced today that it has been awarded a [...]
Scapa Healthcare Unveils Three R&D Centers of Excellence in U.S. and Europe for Development of Innovative, Turn-key, Skin-Friendly Solutions
27/02/2018
WINDSOR, Conn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions, unveiled its three R&D Centers of Excellence . Each Center offers full [...]
Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Using Lipid Nanoparticle (LNP) Delivery Technology
27/02/2018
Intellia researchers achieved 97 percent reduction in serum transthyretin protein levels in mice through a single administration, with a durability of at least 12 months CRISPR/Cas9 administered via LNP was well- [...]
Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call
27/02/2018
CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing treatments for severe neurological diseases, today announced [...]
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
27/02/2018
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical ingredients (APIs), and [...]
Aptevo Therapeutics to Present at the 30th Annual ROTH Conference
27/02/2018
SEATTLE, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]
Sun Biopharma, Inc. Files United States Patent Protecting the Manufacturing Process for Its Lead Drug Candidate, SBP-101
27/02/2018
MINNEAPOLIS, MN, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today [...]
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018
27/02/2018
WARSAW, Ind., Feb. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, [...]
AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
27/02/2018
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution of proprietary current [...]
Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th
27/02/2018
REDWOOD CITY, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that its fourth quarter and full year 2017 financial results will be released after market close on [...]
Data From SELLAS Life Sciences’ Positive Phase 2 Acute Myeloid Leukemia Study Published in American Society of Hematology’s Journal, Blood Advances
27/02/2018
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]

Pages